Clexane (enoxaparin) versus Fragmin (dalteparin) for thromboprophylaxis in total hip replacement surgery (THR);KLEXANE (ENOXAPARIN) ELLER FRAGMIN (DALTEPARIN) SOM TROMBOSEPROFYLAKSE VED HOFTEKIRURGI?

Tidsskrift for den Norske Laegeforening

Volumn 116, Issue 15, 1996, Pages 1782-1784

  Cjengedal, Erling ^a   Uppheim, Gisle ^a  

^a Kirurgisk Avdeling   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

DALTEPARIN; ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ADULT; AGED; ARTICLE; BLEEDING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; HUMAN; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOSIS; TOTAL HIP PROSTHESIS;

AGED; COST SAVINGS; DALTEPARIN; DRUG COSTS; ENOXAPARIN; FEMALE; FIBRINOLYTIC AGENTS; HIP PROSTHESIS; HUMANS; MALE; MIDDLE AGED; NORWAY; THERAPEUTIC EQUIVALENCY; THROMBOLYTIC THERAPY;

EID: 0029943887     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Eriksson BI, Zachrisson BE, Tegner-Nilsson AC, Risberg B. Thrombosis prophylaxis with low molecular weight heparin in total hip replacement. Br J Surg 1988; 75: 1053-7.
2. Eriksson BI, Kælebo P, Antmyhr BA, Wadenvik H, Tengborn L, Risberg B. Prevention of deep-vein thrombosis and pulmonary embolism after total hip replacement. J Bone Surg Am 1991; 73: 484-93.
3. Nurmohamed MT, Rosendaal FR, Büller HR, Dekker E, Hommes DW, Vandenbroucke JP et al. Low-molecular-weight heparin versus standard heparin in general and orthopedic surgery: a meta-analysis. Lancet 1992; 340: 152-6.
4. Bergqvist D, Review of clinical trials of low molecular weight heparins. Eur J Surg 1992; 158: 67-78.
5. Leizorovics A, Haugh MC, Chapuis F-R, Samama MM, Boissel J-P. Low molecular weight heparin in prevention of perioperativ thrombosis. BMJ 1992; 305: 913-20.
6. Jørgensen LN, Willie-Jørgensen P, Hauch O. Prophylaxis of post-operativ thromboembolism with low molecular weight heparins. Br J Surg 1993; 80: 689-704.
7. Planes A, Vochelle N, Mazas F, Manzat C, Zucman J, Landais A et al. Prevention of postoperative venous thrombosis: a randomized trial comparing unfractioned heparin with low-molecular-weight heparin in patients undergoing total hip replacement. Thromb Haemost 1988; 60: 407-10.
8. Turpie AGG, Levine MN, Hirsh J, Carter CJ, Jay RM, Powers PJ et al. A randomized controlled trial of a low-molecular-weight heparin (enoxaparin) to prevent deep vein thrombosis in patients undergoing elective hip surgery. N Engl J Med 1986; 315: 925-9.
9. Abildgaard U. Hva er adekvat postoperativ tromboseprofylakse i dag? Tidsskr Nor Lægeforen 1991; 111: 714-5.
10. Wærstad A, Westbye O, Beermann B, Strandberg K. Workshop; treatment of venous thrombosis and pulmonary embolism. 1995; 3 særtrykk fra Statens legemiddelkontroll & Läkemedelsverket. Oslo: Statens legemiddelkontroll, 1995.
11. Røise O, Nurmohamed M, Reijnders P, Touzard R, Stiekema J, Bachman F et al. A multicenter randomized assessor-blind pilot study comparing the efficacy in the prophylaxis of DVT and the safety of Orgaran (Org 10172) Fragmin, Clexane/Lovenox in patients undergoing surgery for a fractured hip. Thromb Haemost 1993; 69: 620.
12. Bang CJ, Talstad I, Berstad A. Bleeding effects of unfractionated heparin and low molecular weight heparins in an animal model. Eur J Surg 1994; 160 (suppl 571): 23-9.
13. Fareed JM, Walenga M, Lassen L, Borris D, Hoppensteath D, Murphy R et al. Pharmacologic profile of a low molecular weight heparin (enoxaparin): experimental and clinical validation of the prophylactic antithrombotic effects. Acta Chir Scand Suppl 1990; 556: 75-90.
14. Eriksson BI, Søderberg K, Widlund L. Wandell B, Tengbom L, Risberg B. A comparative study of three low-molecular weight heparins (LMWH) and unfractionated heparin (UH) in healthy volunteers. Thromb Hæmost 1995, 73: 398-401.
15. Warwick D, Bannister GC, Williams MH. Death and thromboembolic disease after total hip replacement. J Bone Joint Surg Br 1995, 77: 6-10.
16. Buckley MM, Sorkin EM. Enoxaparin. Drugs 1992; 44: 465-97.
17. Harrington P, Byrne J. The effect of the surgical approach to the hip joint on venous blood flow and venous thrombosis after total hip arthroplasty. J Bone Joint Surg 1995; (suppl II): 172.
18. Levine MN, Planes A, Hirsh J, Goodyear M, Vochelle N, Gent M. The relationship between anti-factor Xa level and clinical outcome in parients receiving Enoxaparine LMWH to prevent deep vein thrombosis after hip replacement Thromb Haemost 1989; 62: 940-4.